Physician profile
Siroth Charnond
NPI 1265421218
$1,931.45
in general payments reported to CMS, 2019-2025
21 companies · $34.69 in 2025
The $34.69 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $668 · 2020: $488 · 2021: $480 · 2022: $229 · 2023: $31.57 · 2025: $34.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $66.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $66.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $572.52 | 2019-2023 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $218.62 | 2019-2021 | |
| Amgen INC. | $186.46 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $145.68 | 2019-2021 | |
| Pfizer INC. | $133.33 | 2019-2021 | |
| Astellas Pharma US INC | $99.71 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $80.43 | 2019-2020 | |
| Glaxosmithkline, LLC. | $76.68 | 2019 | |
| Lilly USA, LLC | $63.18 | 2020-2022 | |
| Amarin Pharma, INC. | $51.61 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $48.65 | 2019 | |
| Eisai INC. | $48.55 | 2021 | |
| Merck Sharp & Dohme LLC | $43.84 | 2019-2021 | |
| Abbott Laboratories | $41.25 | 2021 | |
| Exact Sciences Corporation | $34.69 | 2025 | The Cologuard Plus Collection Kit |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $16.25 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.94 | 2019 | |
| Esperion Therapeutics, INC. | $14.77 | 2020 | |
| Mylan Specialty L.P. | $13.93 | 2021 | |
| Dexcom, INC. | $13.57 | 2022 | |
| Sanofi-Aventis U.S. LLC | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Siroth Charnond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.